AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 273: E1113-E1120, 1997;
0193-1849/97 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cornish, J.
Right arrow Articles by Reid, I. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cornish, J.
Right arrow Articles by Reid, I. R.
Vol. 273, Issue 6, E1113-E1120, December 1997

Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo

Jillian Cornish1, Karen E. Callon1, David H. Coy3, Ning-Yi Jiang3, Liqun Xiao1, Garth J. S. Cooper1,2, and Ian R. Reid1

1 Department of Medicine and 2 School of Biological Sciences, University of Auckland, Auckland, New Zealand; and 3 Peptide Research Laboratories, Tulane University Medical Center, New Orleans, Louisiana 70112

Adrenomedullin is a 52-amino acid vasodilator peptide produced in many tissues, including bone. It has 20% sequence identity with amylin, a regulator of osteoblast growth, and circulates in picomolar concentrations. The present study assesses whether adrenomedullin also acts on osteoblasts. At concentrations of 10-12 M and greater, adrenomedullin produced a dose-dependent increase in cell number and [3H]thymidine incorporation in cultures of fetal rat osteoblasts. This effect was also seen with adrenomedullin-(15---52), -(22---52), and -(27---52), but adrenomedullin-(40---52) was inactive. These effects were lost in the presence of amylin blockers, suggesting they were mediated by the amylin receptor. Adrenomedullin also increased [3H]thymidine incorporation into cultured neonatal mouse calvaria but, unlike amylin, did not reduce bone resorption in this model. Adrenomedullin stimulated phenylalanine incorporation into both isolated osteoblasts and calvaria. When injected daily for 5 days over the calvariae of adult mice, it increased indexes of bone formation two- to threefold (P < 0.0001) and increased mineralized bone area by 14% (P = 0.004). It is concluded that adrenomedullin regulates osteoblast function and that it increases bone mass in vivo. The potential of this family of peptides in the therapy of osteoporosis should be further evaluated.

amylin; calvaria; bone resorption; peptide fragments


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. Cornish, K. E. Callon, J. A. Gasser, U. Bava, E. M. Gardiner, D. H. Coy, G. J. S. Cooper, and I. R. Reid
Systemic administration of a novel octapeptide, amylin-(1---8), increases bone volume in male mice
Am J Physiol Endocrinol Metab, October 1, 2000; 279(4): E730 - E735.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. Cornish, K. E. Callon, A. R. King, G. J. S. Cooper, and I. R. Reid
Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice
Am J Physiol Endocrinol Metab, October 1, 1998; 275(4): E694 - E699.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. Cornish, K. E. Callon, C. Q.-X. Lin, C. L. Xiao, T. B. Mulvey, D. H. Coy, G. J. S. Cooper, and I. R. Reid
Dissociation of the effects of amylin on osteoblast proliferation and bone resorption
Am J Physiol Endocrinol Metab, May 1, 1998; 274(5): E827 - E833.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online